"We opened our doors in 1926 and today, we staff a 360-bed acute care hospital that offers a full range of clinical services, including general medicine, surgery, a birthing center, a Primary Stroke Center, and 24-hour emergency care. Our services don’t stop when you leave our campus. Our leaders make it a priority to bring our services into the Downriver community."

During the past decade, Henry Ford Wyandotte Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Henry Ford Wyandotte Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 5 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Uelk, J. Daniel, D.O." with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "University of Michigan" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Ford Wyandotte Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Blue Cross Blue Shield of Michigan Foundation" with 1 trials as a collaborator and "Coloplast A/S" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Henry Ford Wyandotte Hospital" are "Pathology" (2 trials), "Stage II Breast Cancer" (2 trials), "Stage IIIA Breast Cancer" (2 trials), "Thyroid Gland Carcinoma" (2 trials) and "ALK Gene Rearrangement" (1 trials). Many other conditions were trialed in "Henry Ford Wyandotte Hospital" in a lesser frequency.

Most popular intervention types in "Henry Ford Wyandotte Hospital" are "Procedure" (7 trials), "Drug" (6 trials), "Other" (5 trials), "Biological" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (4 trials), "Computed Tomography" (4 trials), "Nivolumab" (4 trials), "Crizotinib" (3 trials) and "Laboratory Biomarker Analysis" (3 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Wyandotte Hospital" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Henry Ford Wyandotte Hospital". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Henry Ford Wyandotte Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Wyandotte Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Henry Ford Wyandotte Hospital has several departments that took part in Clinical trials: "Henry Ford Cancer Institute-Downriver" - 117 trials